NGM

NGM Biopharmaceuticals, Inc. Common Stock

Delisted

NGM was delisted on the 4th of April, 2024.

119 hedge funds and large institutions have $833M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 43 increasing their positions, 33 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
-1
Holders Change %
-0.83%
% of All Funds
1.84%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
19
Increased
43
Reduced
33
Closed
18
Calls
$1.61M
Puts
$24K
Net Calls
+$1.58M
Net Calls Change
-$3.78M
Name Holding Trade Value Shares
Change
Shares
Change %
PL
126
Parkwood LLC
Ohio
-$1.05M -50,000 Closed
TD Asset Management
127
TD Asset Management
Ontario, Canada
-$639K -30,400 Closed
Walleye Capital
128
Walleye Capital
New York
-$470 -22,368 Closed
Principal Financial Group
129
Principal Financial Group
Iowa
-$307K -14,628 Closed
Handelsbanken Fonder
130
Handelsbanken Fonder
Sweden
-$210K -10,000 Closed
SPIA
131
Steward Partners Investment Advisory
New York
-$42K -2,000 Closed
CG
132
Cutler Group
California
-$37K -1,800 Closed
PCM
133
Penserra Capital Management
California
-$37K -1,765 Closed
FDCDDQ
134
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$15K -714 Closed
TWA
135
TCI Wealth Advisors
Arizona
-$3K -140 Closed